Shenzhen Salubris Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 11.9% in First Quarter of 2023

Shenzhen Salubris Pharmaceuticals Co.,Ltd. (深圳信立泰药业股份有限公司) (002294.SZ) reported a net profit of 208.7 million yuan in the first quarter of 2023, down 11.9% year-on-year.

Meanwhile, the company posted 887.5 million yuan in revenue, down 5.1% year-on-year.

At the end of the reporting period, it had 9.7 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 15.4%.